Search

everythinglearnresearchcommunity

for

Search:↓

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

Enzymes play crucial roles in metabolism, health, and disease management.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Leontopodium alpinum extract may help reduce hair shedding by keeping hair in the growth phase longer.

Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.

Natural compounds may help treat advanced papillary thyroid cancer by targeting specific molecular pathways.

Topical ruxolitinib cream may help treat frontal fibrosing alopecia.

JAK inhibitors show promise for treating various skin diseases.

Baricitinib can cause excessive hair growth.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

Topical JAK inhibitors may help children with alopecia areata regrow hair.

Alopecia areata is caused by immune system issues, and JAK inhibitors might help treat it.

Janus kinase inhibitors are effective and safe for treating Alopecia Areata.

Naringin may help treat atopic dermatitis by reducing inflammation and improving the skin barrier.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

In 2017, pediatric dermatology advanced with new treatments and insights into various skin conditions in children.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.

Future alopecia treatments will improve with targeted therapies and personalized approaches.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

JAK inhibitors offer new hope for treating severe alopecia areata.

Systemic treatments like hydroxychloroquine and cyclosporine A help with Lichen Planopilaris and Frontal Fibrosing Alopecia, but ongoing treatment is needed.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Alopecia Areata affects 2% globally, with treatments like essential oils, garlic, and JAK inhibitors showing promise, but more research is needed.

Tailored treatments for alopecia areata are recommended based on severity and patient needs.

Natural antioxidants like flavonoids and resveratrol may help prevent low testosterone in aging men.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Treat alopecia areata with personalized plans, using corticosteroids for mild cases and Janus Kinase inhibitors for severe cases, while also offering psychological support.

Janus kinase inhibitors are promising for treating scarring alopecia, but more research is needed for safety and personalized treatments.

New treatments for seborrheic dermatitis show promise for difficult cases.